世界の腎臓病治療薬市場2022年:錠剤、カプセル、その他

◆英語タイトル:Global Kidney Disease Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが発行した調査報告書(GIR22MY8871)◆商品コード:GIR22MY8871
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2022年5月(※2025年版があります。お問い合わせください。)
◆ページ数:115
◆レポート形式:英語 / PDF
◆納品方法:Eメール(注文後2-3日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥528,960見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,220 ⇒換算¥793,440見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,057,920見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

腎臓病治療薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の腎臓病治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。

腎臓病治療薬市場は種類と用途によって区分されます。2017年~2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・錠剤、カプセル、その他

用途別セグメントは次のように区分されます。
・慢性糸球体腎炎、腎症候群、慢性腎不全、腎臓結石、腎嚢胞腎(多発性嚢胞腎)、糖尿病性腎症、高血圧性腎症、紫斑病、ループス腎炎、小児腎疾患

世界の腎臓病治療薬市場の主要な市場プレーヤーは以下のとおりです。
・GlaxoSmithKline、Sanofi、Roche、Pfizer、AstraZeneca、Keryx Biopharmaceuticals、Kissei Pharmaceutical、AbbVie、Amgen、Teva Pharmaceutical Industries、Tianjin Tongrentang Group、Jiangxi Jimin Kexin Jinshuibao Pharmaceutical、Datong Liqun Pharmaceutical、Hebei Ruisen Pharmaceutical、Changxing Pharmaceutical、zhejiang Shengbokang Pharmaceutical

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、腎臓病治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な腎臓病治療薬メーカーの企業概要、2019年~2022年までの腎臓病治療薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な腎臓病治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年~2028年までの地域別腎臓病治療薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年~2028年までの腎臓病治療薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2028年までの主要地域での腎臓病治療薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および腎臓病治療薬の産業チェーンを掲載しています。
・第13、14、15章では、腎臓病治療薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):GlaxoSmithKline、Sanofi、Roche、Pfizer、AstraZeneca、Keryx Biopharmaceuticals、Kissei Pharmaceutical、AbbVie、Amgen、Teva Pharmaceutical Industries、Tianjin Tongrentang Group、Jiangxi Jimin Kexin Jinshuibao Pharmaceutical、Datong Liqun Pharmaceutical、Hebei Ruisen Pharmaceutical、Changxing Pharmaceutical、zhejiang Shengbokang Pharmaceutical
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年:錠剤、カプセル、その他
・用途別分析2017年-2028年:慢性糸球体腎炎、腎症候群、慢性腎不全、腎臓結石、腎嚢胞腎(多発性嚢胞腎)、糖尿病性腎症、高血圧性腎症、紫斑病、ループス腎炎、小児腎疾患
・腎臓病治療薬の北米市場規模2017年-2028年:アメリカ、カナダ、メキシコ
・腎臓病治療薬のヨーロッパ市場規模2017年-2028年:ドイツ、イギリス、フランス、ロシア、イタリア
・腎臓病治療薬のアジア市場規模2017年-2028年:中国、日本、韓国、インド、東南アジア、オーストラリア
・腎臓病治療薬の南米市場規模2017年-2028年:ブラジル、アルゼンチン
・腎臓病治療薬の中東・アフリカ市場規模2017年-2028年:サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Kidney Disease Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Kidney Disease Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Chronic Glomerulonephritis accounting for % of the Kidney Disease Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Tablets segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Kidney Disease Drugs include GlaxoSmithKline, Sanofi, Roche, Pfizer, and AstraZeneca, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Kidney Disease Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Tablets
Capsule
Other
Market segment by Application can be divided into
Chronic Glomerulonephritis
Nephrotic Syndrome
Chronic Renal Failure
Kidney Stones
Renal Cyst (polycystic Kidney)
Diabetic Nephropathy
Hypertensive Nephropathy
Purpura Nephritis
Lupus Nephritis
Pediatric Kidney Disease
The key market players for global Kidney Disease Drugs market are listed below:
GlaxoSmithKline
Sanofi
Roche
Pfizer
AstraZeneca
Keryx Biopharmaceuticals
Kissei Pharmaceutical
AbbVie
Amgen
Teva Pharmaceutical Industries
Tianjin Tongrentang Group
Jiangxi Jimin Kexin Jinshuibao Pharmaceutical
Datong Liqun Pharmaceutical
Hebei Ruisen Pharmaceutical
Changxing Pharmaceutical
zhejiang Shengbokang Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Kidney Disease Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Kidney Disease Drugs, with price, sales, revenue and global market share of Kidney Disease Drugs from 2019 to 2022.
Chapter 3, the Kidney Disease Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Kidney Disease Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Kidney Disease Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Kidney Disease Drugs.
Chapter 13, 14, and 15, to describe Kidney Disease Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Kidney Disease Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Kidney Disease Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Tablets
1.2.3 Capsule
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Kidney Disease Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Chronic Glomerulonephritis
1.3.3 Nephrotic Syndrome
1.3.4 Chronic Renal Failure
1.3.5 Kidney Stones
1.3.6 Renal Cyst (polycystic Kidney)
1.3.7 Diabetic Nephropathy
1.3.8 Hypertensive Nephropathy
1.3.9 Purpura Nephritis
1.3.10 Lupus Nephritis
1.3.11 Pediatric Kidney Disease
1.4 Global Kidney Disease Drugs Market Size & Forecast
1.4.1 Global Kidney Disease Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Kidney Disease Drugs Sales in Volume (2017-2028)
1.4.3 Global Kidney Disease Drugs Price (2017-2028)
1.5 Global Kidney Disease Drugs Production Capacity Analysis
1.5.1 Global Kidney Disease Drugs Total Production Capacity (2017-2028)
1.5.2 Global Kidney Disease Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Kidney Disease Drugs Market Drivers
1.6.2 Kidney Disease Drugs Market Restraints
1.6.3 Kidney Disease Drugs Trends Analysis
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline Kidney Disease Drugs Product and Services
2.1.4 GlaxoSmithKline Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Kidney Disease Drugs Product and Services
2.2.4 Sanofi Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Kidney Disease Drugs Product and Services
2.3.4 Roche Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Kidney Disease Drugs Product and Services
2.4.4 Pfizer Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca Kidney Disease Drugs Product and Services
2.5.4 AstraZeneca Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Keryx Biopharmaceuticals
2.6.1 Keryx Biopharmaceuticals Details
2.6.2 Keryx Biopharmaceuticals Major Business
2.6.3 Keryx Biopharmaceuticals Kidney Disease Drugs Product and Services
2.6.4 Keryx Biopharmaceuticals Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Kissei Pharmaceutical
2.7.1 Kissei Pharmaceutical Details
2.7.2 Kissei Pharmaceutical Major Business
2.7.3 Kissei Pharmaceutical Kidney Disease Drugs Product and Services
2.7.4 Kissei Pharmaceutical Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 AbbVie
2.8.1 AbbVie Details
2.8.2 AbbVie Major Business
2.8.3 AbbVie Kidney Disease Drugs Product and Services
2.8.4 AbbVie Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Amgen
2.9.1 Amgen Details
2.9.2 Amgen Major Business
2.9.3 Amgen Kidney Disease Drugs Product and Services
2.9.4 Amgen Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Teva Pharmaceutical Industries
2.10.1 Teva Pharmaceutical Industries Details
2.10.2 Teva Pharmaceutical Industries Major Business
2.10.3 Teva Pharmaceutical Industries Kidney Disease Drugs Product and Services
2.10.4 Teva Pharmaceutical Industries Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Tianjin Tongrentang Group
2.11.1 Tianjin Tongrentang Group Details
2.11.2 Tianjin Tongrentang Group Major Business
2.11.3 Tianjin Tongrentang Group Kidney Disease Drugs Product and Services
2.11.4 Tianjin Tongrentang Group Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical
2.12.1 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Details
2.12.2 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Major Business
2.12.3 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Product and Services
2.12.4 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Datong Liqun Pharmaceutical
2.13.1 Datong Liqun Pharmaceutical Details
2.13.2 Datong Liqun Pharmaceutical Major Business
2.13.3 Datong Liqun Pharmaceutical Kidney Disease Drugs Product and Services
2.13.4 Datong Liqun Pharmaceutical Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Hebei Ruisen Pharmaceutical
2.14.1 Hebei Ruisen Pharmaceutical Details
2.14.2 Hebei Ruisen Pharmaceutical Major Business
2.14.3 Hebei Ruisen Pharmaceutical Kidney Disease Drugs Product and Services
2.14.4 Hebei Ruisen Pharmaceutical Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Changxing Pharmaceutical
2.15.1 Changxing Pharmaceutical Details
2.15.2 Changxing Pharmaceutical Major Business
2.15.3 Changxing Pharmaceutical Kidney Disease Drugs Product and Services
2.15.4 Changxing Pharmaceutical Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 zhejiang Shengbokang Pharmaceutical
2.16.1 zhejiang Shengbokang Pharmaceutical Details
2.16.2 zhejiang Shengbokang Pharmaceutical Major Business
2.16.3 zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Product and Services
2.16.4 zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Kidney Disease Drugs Breakdown Data by Manufacturer
3.1 Global Kidney Disease Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Kidney Disease Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Kidney Disease Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Kidney Disease Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Kidney Disease Drugs Manufacturer Market Share in 2021
3.5 Global Kidney Disease Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Kidney Disease Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Kidney Disease Drugs Market Size by Region
4.1.1 Global Kidney Disease Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Kidney Disease Drugs Revenue by Region (2017-2028)
4.2 North America Kidney Disease Drugs Revenue (2017-2028)
4.3 Europe Kidney Disease Drugs Revenue (2017-2028)
4.4 Asia-Pacific Kidney Disease Drugs Revenue (2017-2028)
4.5 South America Kidney Disease Drugs Revenue (2017-2028)
4.6 Middle East and Africa Kidney Disease Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Kidney Disease Drugs Sales in Volume by Type (2017-2028)
5.2 Global Kidney Disease Drugs Revenue by Type (2017-2028)
5.3 Global Kidney Disease Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Kidney Disease Drugs Sales in Volume by Application (2017-2028)
6.2 Global Kidney Disease Drugs Revenue by Application (2017-2028)
6.3 Global Kidney Disease Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Kidney Disease Drugs Sales by Type (2017-2028)
7.2 North America Kidney Disease Drugs Sales by Application (2017-2028)
7.3 North America Kidney Disease Drugs Market Size by Country
7.3.1 North America Kidney Disease Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Kidney Disease Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Kidney Disease Drugs Sales by Type (2017-2028)
8.2 Europe Kidney Disease Drugs Sales by Application (2017-2028)
8.3 Europe Kidney Disease Drugs Market Size by Country
8.3.1 Europe Kidney Disease Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Kidney Disease Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Kidney Disease Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Kidney Disease Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Kidney Disease Drugs Market Size by Region
9.3.1 Asia-Pacific Kidney Disease Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Kidney Disease Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Kidney Disease Drugs Sales by Type (2017-2028)
10.2 South America Kidney Disease Drugs Sales by Application (2017-2028)
10.3 South America Kidney Disease Drugs Market Size by Country
10.3.1 South America Kidney Disease Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Kidney Disease Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Kidney Disease Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Kidney Disease Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Kidney Disease Drugs Market Size by Country
11.3.1 Middle East & Africa Kidney Disease Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Kidney Disease Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Kidney Disease Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Kidney Disease Drugs
12.3 Kidney Disease Drugs Production Process
12.4 Kidney Disease Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Kidney Disease Drugs Typical Distributors
13.3 Kidney Disease Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Kidney Disease Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Kidney Disease Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 4. GlaxoSmithKline Major Business
Table 5. GlaxoSmithKline Kidney Disease Drugs Product and Services
Table 6. GlaxoSmithKline Kidney Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Sanofi Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Major Business
Table 9. Sanofi Kidney Disease Drugs Product and Services
Table 10. Sanofi Kidney Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Roche Basic Information, Manufacturing Base and Competitors
Table 12. Roche Major Business
Table 13. Roche Kidney Disease Drugs Product and Services
Table 14. Roche Kidney Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Pfizer Basic Information, Manufacturing Base and Competitors
Table 16. Pfizer Major Business
Table 17. Pfizer Kidney Disease Drugs Product and Services
Table 18. Pfizer Kidney Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 20. AstraZeneca Major Business
Table 21. AstraZeneca Kidney Disease Drugs Product and Services
Table 22. AstraZeneca Kidney Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Keryx Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Keryx Biopharmaceuticals Major Business
Table 25. Keryx Biopharmaceuticals Kidney Disease Drugs Product and Services
Table 26. Keryx Biopharmaceuticals Kidney Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Kissei Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 28. Kissei Pharmaceutical Major Business
Table 29. Kissei Pharmaceutical Kidney Disease Drugs Product and Services
Table 30. Kissei Pharmaceutical Kidney Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. AbbVie Basic Information, Manufacturing Base and Competitors
Table 32. AbbVie Major Business
Table 33. AbbVie Kidney Disease Drugs Product and Services
Table 34. AbbVie Kidney Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Amgen Basic Information, Manufacturing Base and Competitors
Table 36. Amgen Major Business
Table 37. Amgen Kidney Disease Drugs Product and Services
Table 38. Amgen Kidney Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 40. Teva Pharmaceutical Industries Major Business
Table 41. Teva Pharmaceutical Industries Kidney Disease Drugs Product and Services
Table 42. Teva Pharmaceutical Industries Kidney Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Tianjin Tongrentang Group Basic Information, Manufacturing Base and Competitors
Table 44. Tianjin Tongrentang Group Major Business
Table 45. Tianjin Tongrentang Group Kidney Disease Drugs Product and Services
Table 46. Tianjin Tongrentang Group Kidney Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 48. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Major Business
Table 49. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Product and Services
Table 50. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Datong Liqun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 52. Datong Liqun Pharmaceutical Major Business
Table 53. Datong Liqun Pharmaceutical Kidney Disease Drugs Product and Services
Table 54. Datong Liqun Pharmaceutical Kidney Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Hebei Ruisen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 56. Hebei Ruisen Pharmaceutical Major Business
Table 57. Hebei Ruisen Pharmaceutical Kidney Disease Drugs Product and Services
Table 58. Hebei Ruisen Pharmaceutical Kidney Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Changxing Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 60. Changxing Pharmaceutical Major Business
Table 61. Changxing Pharmaceutical Kidney Disease Drugs Product and Services
Table 62. Changxing Pharmaceutical Kidney Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. zhejiang Shengbokang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 64. zhejiang Shengbokang Pharmaceutical Major Business
Table 65. zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Product and Services
Table 66. zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Global Kidney Disease Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 68. Global Kidney Disease Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 69. Market Position of Manufacturers in Kidney Disease Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 70. Global Kidney Disease Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 71. Head Office and Kidney Disease Drugs Production Site of Key Manufacturer
Table 72. Kidney Disease Drugs New Entrant and Capacity Expansion Plans
Table 73. Kidney Disease Drugs Mergers & Acquisitions in the Past Five Years
Table 74. Global Kidney Disease Drugs Sales by Region (2017-2022) & (K Units)
Table 75. Global Kidney Disease Drugs Sales by Region (2023-2028) & (K Units)
Table 76. Global Kidney Disease Drugs Revenue by Region (2017-2022) & (USD Million)
Table 77. Global Kidney Disease Drugs Revenue by Region (2023-2028) & (USD Million)
Table 78. Global Kidney Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 79. Global Kidney Disease Drugs Sales by Type (2023-2028) & (K Units)
Table 80. Global Kidney Disease Drugs Revenue by Type (2017-2022) & (USD Million)
Table 81. Global Kidney Disease Drugs Revenue by Type (2023-2028) & (USD Million)
Table 82. Global Kidney Disease Drugs Price by Type (2017-2022) & (US$/Unit)
Table 83. Global Kidney Disease Drugs Price by Type (2023-2028) & (US$/Unit)
Table 84. Global Kidney Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 85. Global Kidney Disease Drugs Sales by Application (2023-2028) & (K Units)
Table 86. Global Kidney Disease Drugs Revenue by Application (2017-2022) & (USD Million)
Table 87. Global Kidney Disease Drugs Revenue by Application (2023-2028) & (USD Million)
Table 88. Global Kidney Disease Drugs Price by Application (2017-2022) & (US$/Unit)
Table 89. Global Kidney Disease Drugs Price by Application (2023-2028) & (US$/Unit)
Table 90. North America Kidney Disease Drugs Sales by Country (2017-2022) & (K Units)
Table 91. North America Kidney Disease Drugs Sales by Country (2023-2028) & (K Units)
Table 92. North America Kidney Disease Drugs Revenue by Country (2017-2022) & (USD Million)
Table 93. North America Kidney Disease Drugs Revenue by Country (2023-2028) & (USD Million)
Table 94. North America Kidney Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 95. North America Kidney Disease Drugs Sales by Type (2023-2028) & (K Units)
Table 96. North America Kidney Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 97. North America Kidney Disease Drugs Sales by Application (2023-2028) & (K Units)
Table 98. Europe Kidney Disease Drugs Sales by Country (2017-2022) & (K Units)
Table 99. Europe Kidney Disease Drugs Sales by Country (2023-2028) & (K Units)
Table 100. Europe Kidney Disease Drugs Revenue by Country (2017-2022) & (USD Million)
Table 101. Europe Kidney Disease Drugs Revenue by Country (2023-2028) & (USD Million)
Table 102. Europe Kidney Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 103. Europe Kidney Disease Drugs Sales by Type (2023-2028) & (K Units)
Table 104. Europe Kidney Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 105. Europe Kidney Disease Drugs Sales by Application (2023-2028) & (K Units)
Table 106. Asia-Pacific Kidney Disease Drugs Sales by Region (2017-2022) & (K Units)
Table 107. Asia-Pacific Kidney Disease Drugs Sales by Region (2023-2028) & (K Units)
Table 108. Asia-Pacific Kidney Disease Drugs Revenue by Region (2017-2022) & (USD Million)
Table 109. Asia-Pacific Kidney Disease Drugs Revenue by Region (2023-2028) & (USD Million)
Table 110. Asia-Pacific Kidney Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 111. Asia-Pacific Kidney Disease Drugs Sales by Type (2023-2028) & (K Units)
Table 112. Asia-Pacific Kidney Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 113. Asia-Pacific Kidney Disease Drugs Sales by Application (2023-2028) & (K Units)
Table 114. South America Kidney Disease Drugs Sales by Country (2017-2022) & (K Units)
Table 115. South America Kidney Disease Drugs Sales by Country (2023-2028) & (K Units)
Table 116. South America Kidney Disease Drugs Revenue by Country (2017-2022) & (USD Million)
Table 117. South America Kidney Disease Drugs Revenue by Country (2023-2028) & (USD Million)
Table 118. South America Kidney Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 119. South America Kidney Disease Drugs Sales by Type (2023-2028) & (K Units)
Table 120. South America Kidney Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 121. South America Kidney Disease Drugs Sales by Application (2023-2028) & (K Units)
Table 122. Middle East & Africa Kidney Disease Drugs Sales by Region (2017-2022) & (K Units)
Table 123. Middle East & Africa Kidney Disease Drugs Sales by Region (2023-2028) & (K Units)
Table 124. Middle East & Africa Kidney Disease Drugs Revenue by Region (2017-2022) & (USD Million)
Table 125. Middle East & Africa Kidney Disease Drugs Revenue by Region (2023-2028) & (USD Million)
Table 126. Middle East & Africa Kidney Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 127. Middle East & Africa Kidney Disease Drugs Sales by Type (2023-2028) & (K Units)
Table 128. Middle East & Africa Kidney Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 129. Middle East & Africa Kidney Disease Drugs Sales by Application (2023-2028) & (K Units)
Table 130. Kidney Disease Drugs Raw Material
Table 131. Key Manufacturers of Kidney Disease Drugs Raw Materials
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Kidney Disease Drugs Typical Distributors
Table 135. Kidney Disease Drugs Typical Customers
List of Figures
Figure 1. Kidney Disease Drugs Picture
Figure 2. Global Kidney Disease Drugs Revenue Market Share by Type in 2021
Figure 3. Tablets
Figure 4. Capsule
Figure 5. Other
Figure 6. Global Kidney Disease Drugs Revenue Market Share by Application in 2021
Figure 7. Chronic Glomerulonephritis
Figure 8. Nephrotic Syndrome
Figure 9. Chronic Renal Failure
Figure 10. Kidney Stones
Figure 11. Renal Cyst (polycystic Kidney)
Figure 12. Diabetic Nephropathy
Figure 13. Hypertensive Nephropathy
Figure 14. Purpura Nephritis
Figure 15. Lupus Nephritis
Figure 16. Global Kidney Disease Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 17. Global Kidney Disease Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 18. Global Kidney Disease Drugs Sales (2017-2028) & (K Units)
Figure 19. Global Kidney Disease Drugs Price (2017-2028) & (US$/Unit)
Figure 20. Global Kidney Disease Drugs Production Capacity (2017-2028) & (K Units)
Figure 21. Global Kidney Disease Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 22. Kidney Disease Drugs Market Drivers
Figure 23. Kidney Disease Drugs Market Restraints
Figure 24. Kidney Disease Drugs Market Trends
Figure 25. Global Kidney Disease Drugs Sales Market Share by Manufacturer in 2021
Figure 26. Global Kidney Disease Drugs Revenue Market Share by Manufacturer in 2021
Figure 27. Kidney Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 28. Top 3 Kidney Disease Drugs Manufacturer (Revenue) Market Share in 2021
Figure 29. Top 6 Kidney Disease Drugs Manufacturer (Revenue) Market Share in 2021
Figure 30. Global Kidney Disease Drugs Sales Market Share by Region (2017-2028)
Figure 31. Global Kidney Disease Drugs Revenue Market Share by Region (2017-2028)
Figure 32. North America Kidney Disease Drugs Revenue (2017-2028) & (USD Million)
Figure 33. Europe Kidney Disease Drugs Revenue (2017-2028) & (USD Million)
Figure 34. Asia-Pacific Kidney Disease Drugs Revenue (2017-2028) & (USD Million)
Figure 35. South America Kidney Disease Drugs Revenue (2017-2028) & (USD Million)
Figure 36. Middle East & Africa Kidney Disease Drugs Revenue (2017-2028) & (USD Million)
Figure 37. Global Kidney Disease Drugs Sales Market Share by Type (2017-2028)
Figure 38. Global Kidney Disease Drugs Revenue Market Share by Type (2017-2028)
Figure 39. Global Kidney Disease Drugs Price by Type (2017-2028) & (US$/Unit)
Figure 40. Global Kidney Disease Drugs Sales Market Share by Application (2017-2028)
Figure 41. Global Kidney Disease Drugs Revenue Market Share by Application (2017-2028)
Figure 42. Global Kidney Disease Drugs Price by Application (2017-2028) & (US$/Unit)
Figure 43. North America Kidney Disease Drugs Sales Market Share by Type (2017-2028)
Figure 44. North America Kidney Disease Drugs Sales Market Share by Application (2017-2028)
Figure 45. North America Kidney Disease Drugs Sales Market Share by Country (2017-2028)
Figure 46. North America Kidney Disease Drugs Revenue Market Share by Country (2017-2028)
Figure 47. United States Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Canada Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Mexico Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Europe Kidney Disease Drugs Sales Market Share by Type (2017-2028)
Figure 51. Europe Kidney Disease Drugs Sales Market Share by Application (2017-2028)
Figure 52. Europe Kidney Disease Drugs Sales Market Share by Country (2017-2028)
Figure 53. Europe Kidney Disease Drugs Revenue Market Share by Country (2017-2028)
Figure 54. Germany Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. France Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. United Kingdom Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Russia Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Italy Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Asia-Pacific Kidney Disease Drugs Sales Market Share by Region (2017-2028)
Figure 60. Asia-Pacific Kidney Disease Drugs Sales Market Share by Application (2017-2028)
Figure 61. Asia-Pacific Kidney Disease Drugs Sales Market Share by Region (2017-2028)
Figure 62. Asia-Pacific Kidney Disease Drugs Revenue Market Share by Region (2017-2028)
Figure 63. China Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Japan Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Korea Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. India Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Southeast Asia Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Australia Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. South America Kidney Disease Drugs Sales Market Share by Type (2017-2028)
Figure 70. South America Kidney Disease Drugs Sales Market Share by Application (2017-2028)
Figure 71. South America Kidney Disease Drugs Sales Market Share by Country (2017-2028)
Figure 72. South America Kidney Disease Drugs Revenue Market Share by Country (2017-2028)
Figure 73. Brazil Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Argentina Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Middle East & Africa Kidney Disease Drugs Sales Market Share by Type (2017-2028)
Figure 76. Middle East & Africa Kidney Disease Drugs Sales Market Share by Application (2017-2028)
Figure 77. Middle East & Africa Kidney Disease Drugs Sales Market Share by Region (2017-2028)
Figure 78. Middle East & Africa Kidney Disease Drugs Revenue Market Share by Region (2017-2028)
Figure 79. Turkey Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Egypt Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Saudi Arabia Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. South Africa Kidney Disease Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Manufacturing Cost Structure Analysis of Kidney Disease Drugs in 2021
Figure 84. Manufacturing Process Analysis of Kidney Disease Drugs
Figure 85. Kidney Disease Drugs Industrial Chain
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
Figure 87. Methodology
Figure 88. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の腎臓病治療薬市場2022年:錠剤、カプセル、その他(Global Kidney Disease Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。